Table 2 Clinical information of patients between high- and low-risk groups
Overall (126) | High-risk (63) | Low-risk (63) | P value | |
|---|---|---|---|---|
Risk score (median [IQR]) | ||||
3.00 [2.42, 3.73] | 3.74 [3.33, 4.15] | 2.42 [2.04, 2.74] | < 0.001 | |
Gender (%) | ||||
Female | 70 (55.6) | 33 (52.4) | 37 (58.7) | 0.591 |
Male | 56 (44.4) | 30 (47.6) | 26 (41.3) | |
Age (median [IQR]) | ||||
4.30 [2.82, 6.07] | 4.50 [3.40, 6.00] | 4.00 [2.25, 6.05] | 0.307 | |
Histologic classification (%) | ||||
DAWT | 40 (31.7) | 23 (36.5) | 17 (27.0) | 0.339 |
FHWT | 86 (68.3) | 40 (63.5) | 46 (73.0) | |
Stage (%) | ||||
I | 16 (12.7) | 8 (12.7) | 8 (12.7) | 0.663 |
II | 52 (41.3) | 23 (36.5) | 29 (46.0) | |
III | 45 (35.7) | 24 (38.1) | 21 (33.3) | |
IV | 13 (10.3) | 8 (12.7) | 5 (7.9) | |
Vital status (%) | ||||
Alive | 73 (57.9) | 22 (34.9) | 51 (81.0) | < 0.001 |
Dead | 53 (42.1) | 41 (65.1) | 12 (19.0) | |